ReviewMaterials today. Bio2026
Dermal tattoos in biomedicine: Emerging platforms for sensing and therapy.
Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermal tattoos are emerging as a novel class of skin-integrated biomedical platforms that extend beyond body decoration into functional sensing, monitoring, and therapeutic applications. In contrast to conventional biomedical devices, wearable systems, and epidermal electronics, dermal tattoos reside within the dermis, where they can access interstitial fluid, achieve stable tissue integration, and remain protected from surface contamination and mechanical disruption. Although this field is still in its infancy, recent studies have demonstrated the potential of dermal tattoos for a broad range of biomedical uses, particularly in sensing and diagnostics. Reported platforms include colorimetric, fluorescent, photoresponsive, living, and electrophysiological dermal tattoo systems for monitoring biomarkers, electrolytes, ultraviolet exposure, and physiological electrical signals. More recently, dermal tattoos have also begun to expand into treatment, including self-powered bioelectronic systems for wound healing and transient bioresorbable therapeutic interfaces. This review summarizes recent advances in dermal tattoos for biomedicine, focusing on sensing and therapy, along with their materials, fabrication methods, and readout strategies. It also compares dermal tattoos with conventional, wearable, and epidermal systems, and discusses their key opportunities, challenges, and future directions. However, most reported dermal tattoo platforms remain at the proof-of-concept stage, and their clinical translation is still limited by scarce in vivo validation, lack of standardized benchmarking, and limited long-term safety data.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.